Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says
By Janelle Chavez, CNN Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed…
Continue Reading